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Abstract: Autism is well known as a complex developmental disorder with a seemingly confusing and uncertain pathogenesis. 
The deﬁ  nitive mechanisms that promote autism are poorly understood and mostly unknown, yet available theories do appear 
to focus on the disruption of normal cerebral development and its subsequent implications on the functional brain unit. This 
mini-review aims solely to discuss and evaluate the most prominent current theories regarding the pathogenesis of autism. 
The main conclusion is that although there is not a clear pathway of mechanisms directed towards a simple pathogenesis 
and an established link to autism on the symptomatic level; there are however several important theories (neural connectivity, 
neural migration, excitatory-inhibitory neural activity, dendritic morphology, neuroimmune; calcium signalling and mirror 
neurone) which appear to offer an explanation to how autism develops. It seems probable that autism’s neurodevelopmental 
defect is ‘multi-domain’ in origin (rather than a single anomaly) and is hence distributed across numerous levels of study 
(genetic, immunopathogenic, etc.). A more deﬁ  nitive understanding of the pathogenesis could facilitate the development of 
better treatments for this complex psychiatric disorder.
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Introduction
Autism is one of the pervasive developmental disorders (or autism spectrum disorders) and a commonly 
diagnosed condition in child and adolescent psychiatry, which was initially described by the psychiatrist 
Leo Kanner in 1943 (Kanner, 1943). Childhood autism is broadly deﬁ  ned by the presence of abnormal 
and impaired development, which manifests into a series of clinically relevant areas (or symptoms). 
The current prevalence of autism spectrum disorders is estimated at 6 per 1000 (1.3 per 1000 for autism 
itself), with a male/female ratio of 3–4:1 (Fombonne, 2005). Typically the onset of autism is before 
36 months of age (WHO, 2005). Interestingly autism is a highly genetic neuropsychiatric disorder with 
concordance rates of 82%–92% in monozygotic twins (compared with 1%–10% in dizyogtic twins) 
(Persico and Bourgeron, 2006). Autism presents with a triad of core symptoms which include: 
(1) A qualitative impairment of social interaction (an inability to relate to others often with lack of eye 
contact); (2) Stereotypical, ritualistic, repetitive, restrictive patterns of interests, behaviours and activities 
and; (3) Major defects in language development and in other communication skills (WHO 2005; Miall 
et al. 2007). These rather distinctive set of symptoms additionally form the basis of the diagnosis for 
autism. Affected children also manifest with other non-speciﬁ  c symptoms including: unusual sensory 
perception skills and experiences, motor clumsiness (and problems with proprioception) and insomnia. 
The majority of autistic children also have limited intelligence (IQ   100 in 5%). Strongly considered 
differentials for the diagnosis include childhood schizophrenia, learning disability and deafness 
(Fombonne, 2005; WHO, 2005).
The aetiology of autism is complex and is likely to be of multifactorial descent encompassing both 
genetic predisposition and environmental factors (Trottier et al. 1999). Potential genetic disorders include 
fragile X syndrome and tuberous sclerosis (Freitag, 2007). The environmental causative element can 
be effectively separated into pre-natal, peri-natal and post-natal factors. Implicated prenatal factors 
include congenital rubella syndrome (secondary to rubella infection), teratogen exposure (e.g. 
thalidomide) and pesticide exposure. Peri-natal factors are associated with obstetric conditions like low 
birth weight, abnormal gestation length (pre-term delivery) and birth asphyxia (hypoxic-ischaemic 
insult) (Kolevzon, 2007). Post-natal factors encompass a wide range of insults including autoimmune 
disease (Ashwood and van de Water, 2004), leaky gut syndrome (Johnson, 2006), viral infection, 
amygdala developmental failure (Schultz, 2005), oxidative stress (Kern and Jones, 2006), vitamin D 100
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deﬁ  ciency (Cannell, 2007), heavy metal toxicity 
e.g. mercury (Davidson et al. 2004), and the 
controversial MMR vaccine (Wakefield et al. 
1998). Although the aetiology of autism is a highly 
contemporary area of research in psychiatry and 
neuroscience, the focus of this concise review is 
to consider the pathogenesis of autism, an area 
which lacks great certainty with regard to the exact 
underlying neurobiological mechanisms which 
promote this developmental disorder.
The mechanisms that lead to autism are at best 
poorly understood, however they do centre around 
the disruption of normal cerebral development and 
its subsequent implications on the functional 
brain unit (although the exact link to the classic 
triad of core symptoms remains unascertained). 
Numerous neuropsychiatry papers attribute the 
pathogenesis of autism speciﬁ  cally to ‘localised’ 
anomalies (i.e. of neural migration or connectivity), 
which have the potential to detrimentally effect 
CNS structure and function (Casanova, 2007; 
Persico and Bourgeron, 2006). The following aims 
to summarise and discuss the current debated 
theories on autism’s pathogenesis with an emphasis 
on the cellular and molecular neurobiology where 
relevant.
Neural Connectivity
One speciﬁ  c theory emphasises that early brain 
overgrowth and neural overconnectivity are key in 
the pathogenesis. It is speculated that excess 
neuron numbers (inducing cerebral overgrowth) 
may promote defects in neural patterning and 
wiring, with subsequent over energetic short-
distance cortical interactions hindering long-
distance interactions that communicate between 
critical brain regions. Suggesting a more diffuse 
pathology across a multitude of cortical areas 
rather than just a single conﬁ  ned defect. This 
neuroanatomical anomaly has the potential to 
underlie the deficits in socio-emotional and 
communicational function observed in autism 
(Courchesne et al. 2007).
Conversely another related theory postulates 
that the neuropathological basis of disrupted 
cognition in autism is linked to reduced intracortical 
connectivity which subsequently promotes a lower 
degree of information integration across multiple 
cortical regions (Just et al. 2007; Minshew and 
Williams, 2007). Whether or not the pathogenesis 
is due to over- or underconnectivity it is quite 
probable that general neural connectivity and 
inter-neural communication and coordination are 
fundamental contributors to the mechanism of 
autism.
Neural Migration
Cerebral cortical malformations observed in autism 
may result from defective neural migration to the 
cerebral cortex during the ﬁ  rst 6 months of gestation. 
The subsequent cortical dysgenesis seen in autism 
patients with disturbed neural migration includes 
among others; thickened cortex, high neuronal 
density, poor grey-white matter boundaries and 
ectopic grey matter (Schmitz and Rezaie, 2008). 
This hypothesis is additionally supported by the 
fact that decreased levels of Reelin (an extracel-
lular matrix protein that contributes in events that 
are crucial for neuronal migration and cellular 
positioning) have been observed in post-mortem 
cerebellar tissue from autistic patients (Magdaleno 
et al. 2002; Persico and Bourgeron, 2006).
Excitatory-Inhibitory Neural Activity
The theory of unbalanced excitability-inhibitory 
networks in autism also carries certain credibility. 
Available research concludes that chromosomal 
rearrangements involving GABA receptor gene 
clusters are heavily implicated, promoting 
abnormal CNS system excitability and function. 
The additional role of glutamate receptors in 
synaptic maintenance also shows potential 
relevance to autism’s pathophysiology (Dykens 
et al. 2004; Schmitz and Rezaie, 2008). Yet it 
remains unascertained to how exactly abnormalities 
in neuronal excitation and inhibition inﬂ  uence the 
development of autism on the symptomatic level. 
In addition, the mechanism suffers itself from the 
lack of certainty with regard to whether GABA or 
glutamate receptor dysfunction underlies the 
observed excitatory abnormalities.
Dendritic Morphology
The abnormal assembly of synapses and dendritic 
spines may also be a contributing factor in autism’s 
pathogenesis. Notably, it has been found that 
autistic brains feature increased numbers of long, 
thin, dendritic spines (Minshew and Williams, 
2007; Pickett and London, 2005). Crucial to 
dendritic morphology are the scaffolding proteins 
which mediate connectivity between membrane 101
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proteins and cytoskeleton. Specifically the 
SHANK3 gene which encodes a synaptic 
scaffolding protein involved in the induction and 
maintenance of dendritic spines has been observed 
deleted in autism patients (Boeckers et al. 2002).
Neuroimmune Disturbances
The topic of neuroimmune disturbance and its 
impact on the pathogenesis of autism has also been 
widely researched. Immune disorders noted in 
autistic patients include among others: abnormal 
T-helper cell type 1/2 responses, general suppres-
sion of cell-mediated immunity, subnormal levels 
of CD4+ lymphocytes, imbalance of antibody 
levels and reduced natural killer cell functions 
(Cohly and Panja, 2005; Kern and Jones, 2006). 
Autoimmunity could also be linked to autism 
following the ﬁ  nding of autoantibodies (i.e. IgG) 
against nervous system proteins, and additionally 
an immunogenetic association related to the 
presence of human leukocyte antigen molecule 
(HLA) DRB1 and complement C4 alleles may 
underlie a genetic predisposition to neuroimmune 
dysfunction in autism (Ashwood et al. 2006; 
Ashwood and Van de Water, 2004; Sperner-
Unterweger, 2006). The contribution of glial cell 
dysfunction to the pathogenesis of autism is 
another promising area of contemporary research 
(Aschner et al. 1999). On the whole, irregular 
immune activity during vulnerable periods of 
neurodevelopment may be the key to the neural 
dysfunction noted in autism (Ashwood et al. 2006; 
Cohly and Panja, 2005). Although these hypotheses 
carry potential credibility in the ﬁ  eld of autism 
research, the fundamental link cementing the 
association between immunopathology and autism 
(and speciﬁ  cally its neuropsychiatric presentation) 
has yet to be ascertained. Furthermore, the general 
degree of uncertainty with regard to whether the 
immune insult is due to an autoimmune disturbance 
or an immune depressive event is an area which 
undoubtedly requires further investigation.
Calcium Signalling
Calcium signalling may also contribute to autism 
via the important nature of activity-dependant 
calcium inﬂ  ux into neurons which subsequently 
regulates (via transcription) numerous cortical 
excitatory synapses (Shalizi et al. 2006). Altered 
calcium signalling could be a fundamental factor 
in the promotion of dysfunctional synaptogenesis 
and thus autism (Casanova, 2007; Pickett and 
London, 2005). It is possible that the observed 
defects in calcium signalling are also responsible 
for the unbalanced excitatory-inhibitory networks 
discussed earlier, rather than the GABA/glutamate 
receptor abnormalities.
Mirror Neurone System Theory
The favourable mirror neurone system theory links 
neuropathology to autism on a more symptomatic 
level. The mirror neurons themselves are pre-motor 
and parietal cells of the cerebral cortex that ﬁ  re 
action potentials not just when we are in action or 
motion, but when we observe others performing 
similar actions. These neurons essentially ‘mirror’ 
the behaviour of others and provide a suitable 
physiological mechanism for the great scope of 
social behaviours and skills that humans implement 
(i.e. imitation, modelling, empathy and language 
acquisition/evolution). Thus, mirror neurone 
dysfunction could be the central deﬁ  cit observed 
in autism leading to the profound social and com-
munication difficulties experienced (Iacoboni 
and Dapretto, 2006; Schmitz and Rezaie, 2008; 
Williams et al. 2001). Although the mirror neurone 
theory paints a promising view of a simple 
pathogenesis, the connection between the neural 
deﬁ  cit and autism is likely to be speculative at best, 
as it is unlikely that such a small population of 
neurons can account for the great array of psycho-
social and behavioural disturbances encountered 
in autistic children. This point is further enforced 
by the fact that other autistic behaviours (i.e. 
sensory hypersensitivity and excelling at visual 
tasks) cannot be explained by dysfunctional mirror 
neurones (Dinstein, 2008).
Other Theories
Aside from the above theories there are several 
other lines of research into the pathogenesis of 
autism. One such theory involves decreased levels 
of apoptosis (programmed cell death) since sub-
normal levels of Bcl-2 and p53 protein have been 
documented in the cortices of autistic brains 
(Araghi-Niknam and Fatemi, 2003). Whether or 
not the subsequently inappropriate high level of 
neurons interferes in speciﬁ  c way with normal 
brain development is unknown to date, since cur-
rently there is a lack of research in the ﬁ  eld of 
anti-apoptotic insults. However, it does seem prob-
able that excess neurone numbers secondary to the 102
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disordered apoptosis, may promote defects in 
neural connectivity and communication (as detailed 
earlier). Neurotransmitter abnormalities involving 
higher than normal serotonin levels have also been 
implicated in the pathogenesis but with no certain 
link to autism on the symptomatic level. The cause 
of such elevated levels appears to be linked to 
variations in the genes (SLC6A4) coding for the 
serotonin transporter (Penn, 2006; Pino et al. 
2004). Metabolic defects have also been associated 
with autism suggesting inborn errors of metabolism 
as a potential pathogenic factor (Manzi et al. 2008). 
Deficits in cell adhesion molecules, second 
messenger systems and secreted molecules have 
also all been implicated in autism’s rather complex 
pathophysiology (Persico and Bourgeron, 2006).
Summary and Future Directions
It is clear from the above mentioned theories that 
there is not a direct pathway of mechanisms 
pointing towards a simple pathogenesis and an 
explanation of autism’s rather distinctive set of 
symptoms. It seems much more favourable to 
summarise autism’s pathogenesis as being 
multidimensional and uncertain but yet promising 
with regard to some of the aforementioned theories. 
These include: disturbed neural connectivity; 
defective neural migration; unbalanced excitatory-
inhibitory networks; abnormal dendritic 
morphology; neuroimmune disturbances; calcium 
signalling and the mirror neurone system theory. 
Further research in the ﬁ  eld of autism pathogenesis 
should focus on elucidating whether exactly the 
excitation abnormality is due to GABA receptor 
activity suppression or glutamate receptor activity 
elevation or defects in calcium signalling?; whether 
the neuroimmune pathogenic element is due to 
suppression of immune responses or more related 
to autoimmune insults?; why the mirror neurone 
theory cannot explain the great array of behavioural 
and psychosocial symptoms seen in autism?; what 
speciﬁ  c relevance disturbed neural connectivity 
has to autism, and whether there is a valid 
anti-apoptotic link? and finally how all the 
mentioned pathogenic factors interact together (if 
they do at all) to produce a deﬁ  cit in the functional 
brain unit?
Overall it seems most likely that the anomaly 
encountered in neurodevelopment that leads to 
autism is not merely ‘localised’ to a single 
functional neural defect as many theories have 
suggested, but more distributed across numerous 
levels of study (genetic, immunopathogenic, 
neurofunctional etc.) becoming a ‘multi-domain’ 
disorder (Casanova, 2007; Muller, 2007; Persico 
and Bourgeron, 2006). Furthermore, it is worth 
mentioning that of all the theories of autism’s 
pathogenesis, the mirror neurone system theory at 
least provides us with an apparent positive 
connection at the symptomatic level. Future 
investigation into all the theories highlighted in 
this short review could facilitate the development 
of more efﬁ  cacious treatments (pharmacological 
and non-pharmacological) for this complex 
developmental disorder.
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